| David Doezema, MD | |
|
4th Ambulatory Care Ctr, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131-0001 | |
| (505) 272-5062 | |
| Not Available |
| Full Name | David Doezema |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 4th Ambulatory Care Ctr, Albuquerque, New Mexico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437164993 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 78-150 (New Mexico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Doezema, MD 2211 Lomas Blvd Ne, Msc07 4210, Albuquerque, NM 87131-0001 Ph: (505) 272-5062 | David Doezema, MD 4th Ambulatory Care Ctr, 2211 Lomas Blvd. Ne, Albuquerque, NM 87131-0001 Ph: (505) 272-5062 |
News Archive
Researchers from Aston University and Birmingham Children's Hospital have developed a new medication regimen that could successfully treat a bacterial infection that could prove fatal to patients with cystic fibrosis or bronchiectasis. The results of the new study were published in the latest issue of the journal Scientific Reports.
Dr. E. Premkumar Reddy from Temple University School of Medicine and colleagues, in a study examining the effects of Plk1 inhibitor ON01910 on tumor growth in several animal models have found that a small molecule inhibitor of polo-like kinase1 (Plk1) could lead to a new avenue for targeted cancer therapy.
A recent report on the medRxiv* preprint server suggests that a single dose of the Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccine could elicit higher titers of neutralizing antibodies, effectively acting as a booster dose, in people who have already been infected by the SARS-CoV-2.
Hospira, the world's leading provider of injectable drugs and infusion technologies, today announced the European Commission (EC) approval of Inflectra™ (infliximab), Europe's first biosimilar monoclonal antibody (mAb) therapy. Inflectra has been approved for the treatment of inflammatory conditions including rheumatoid arthritis (RA), ankylosing spondylitis, Crohn's disease (CD), ulcerative colitis (UC), psoriatic arthritis (PsA) and psoriasis.
› Verified 2 days ago
Darren M Shafer, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: Pmg Emergency Medicine, 1101 Central Se, Albuquerque, NM 87106 Phone: 505-841-1125 Fax: 505-841-1737 | |
Jessica Mitchell, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 University Of New Mexico, Department Of Emergency Medicine Msc 11 6025, Albuquerque, NM 87131 Phone: 505-272-5062 | |
Nicholas Weiss, D.O. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 2211 Lomas Blvd Ne, Albuquerque, NM 87106 Phone: 505-272-5062 | |
Matthew D Poage, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 5400 Gibson Blvd Se, Albuquerque, NM 87108 Phone: 904-805-1300 Fax: 904-805-1302 | |
Matthew Wilks, Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: Unm Department Of Emergency Medicine Msc11-6025, 1 University Of New Mexico, Albuquerque, NM 87131 Phone: 505-272-5062 Fax: 505-925-7290 | |
Mr. Kyle I Schoenberger, NP Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 3820 Commons Ave Ne, Albuquerque, NM 87109 Phone: 505-343-1711 Fax: 505-343-1862 | |
Daniel M. Gee, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6400 Paseo Del Norte Blvd Ne, Albuquerque, NM 87113 Phone: 505-596-2100 Fax: 505-596-2180 |